WHO WE WORK WITH

    We help Nordic medtech, pharma and health-services companies enter and grow in Brazil, South Africa and the wider region.

    USD 16bn

    Brazil's medical device market in 2025, up 14%

    Source: Medicina S/A

    53m

    Brazilians with a private health plan, 2026

    Source: ANS via O Liberal

    9m

    South Africans has private healthcare, 2025

    Source: Council for Medical Schemes

    Why now

    Why Nordic healthcare companies are looking at the region now

    1. An ageing, chronically ill population.

      32.1 million Brazilians are 60 or older (IBGE Census 2022). 16.6 million adults had diabetes in 2024, rising to 24 million by 2050 (IDF). These are areas where Nordic companies lead.

    2. Local production is now law.

      Brazil's Law 15.471 of 20 July 2026 sets a national strategy for the health industrial complex (Senado). The goal is to raise domestic supply from 42% to 70% of the health system's purchases by 2033 (CFF).

    3. Fewer, larger buyers.

      In Brazil, Rede D'Or, Hapvida and the Dasa–Amil joint venture are consolidating hospitals. In South Africa, Netcare, Life Healthcare and Mediclinic hold about 83% of private beds. Concentrated buyers mean larger contracts and acquisition targets.

    A clean-room production line with rows of glass vials

    Market by market

    Where the healthcare opportunity sits

    Brazil

    9.7% of GDP

    Health spending

    • Health spending was 9.7% of GDP in 2021, the latest official figure: 4.0% public and 5.7% private (IBGE).
    • In 2019, 71.5% of people had no private plan and relied on the public SUS.
    • Brazil was the world's 10th-largest pharma market in 2024 and accounts for 42% of Latin American pharma sales (GTAI).
    • Devices are registered with ANVISA under RDC 751/2022: classes I–II need a notification, and classes III–IV need a full registration, valid for 10 years.

    South Africa

    15.5%

    Medical-scheme cover

    • In 2024, 15.5% of South Africans had medical-scheme cover, rising to 21.3% in Gauteng (Stats SA).
    • About 42% of health spending flows through those private schemes.
    • Any company that makes, imports or distributes devices needs a SAHPRA licence, and more than 2,500 companies hold one.
    • The medtech market is about R21 billion (Engineering News).

    Denmark and the Nordics

    DKK 350bn

    Life-science export target, 2030

    • Life science is Denmark's largest export sector, and the government targets DKK 350 billion of exports by 2030.
    • Nordic strengths in diabetes, chronic care, devices and diagnostics match the region's biggest health needs.

    Elsewhere in the region

    • Mexico is Latin America's second-largest pharma market.
    • Argentina eased imports of medical equipment in 2026.
    • Kenya replaced its national insurance fund with a new Social Health Authority in October 2024.
    • Egypt's universal health insurance covers 5.2 million people in its first phase.
    The Sandton skyline in Johannesburg at dusk
    Simon Jakobsen
    “I spent a decade at Coloplast building businesses across Latin America. The opportunity for Nordic healthcare companies is real, but it is won on registration, reimbursement and distribution, not on product quality alone.”

    Simon Jakobsen

    Managing Partner & Co-Founder

    Ready to discuss your healthcare strategy in Latin America or Africa?

    Contact us